clinicaltrials.gov

ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS-voog

Q: Mis on ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS-voo URL?

Voo aadress on https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=mezagitamab+%28TAK+079%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Kleebi see mis tahes RSS-lugejasse või klõpsa nuppu Jälgi kohe, et lugeda seda Feederis.

Q: Kas ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS-voog töötab?

Jah. Feeder kontrollis seda umbes 1 tund tagasi ja voog vastas tavapäraselt.

Q: Kuidas jälgida voogu ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days Feederis?

Klõpsa nuppu Jälgi kohe ja registreeru, kui sul pole veel kontot. Feederi tasuta pakett hõlmab kuni 200 voogu veebis, iPhone'is ja Androidis. Krediitkaarti pole vaja.

Saa ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days värskeimad uuendused kohe, kui need ilmuvad.

Jälgi kohe < 10 jälgijat

Teave selle voo kohta

Lists interventional clinical trials for mezagitamab (TAK 079) across various phases and conditions, updated within the last 14 days.

Olek: Töötab Kontrollitud umbes 1 tund tagasi, kontrollitakse iga umbes 2 tundi järel
Postitused: Harvem kui kord nädalas Viimane postitus 12 päeva tagasi
Keel: English
Jälgijad: < 10
Veebisait: clinicaltrials.gov
RSS-voo URL: https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=mezagitamab+%28TAK+079%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000

Kontrolli seda voogu RSS-validaatoris

Otsi mõne teise saidi RSS-voogu

Uusimad postitused

Loe ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days postitusi seal, kus sulle sobib

Jälgi Feederis Loe seda koos kõige muuga, mida jälgid, veebis, iPhone'is ja Androidis. E-posti uudiskirjad Muuda oma lugemine uudiskirjaks, Feederist lahkumata. RSS Telegrami Sinu vood otse Telegrami. Toida oma tehisaru Ühenda Claude, ChatGPT ja Cursor MCP kaudu oma voogudega AI-kokkuvõtted Saa põhiidee kätte koos allikatega, mida kontrollida. Tekst kõneks Muuda oma lugemisloend taskuhäälinguks.

Küsimused

Mis on ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS-voo URL?

Voo aadress on https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=mezagitamab+%28TAK+079%29&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Kleebi see mis tahes RSS-lugejasse või klõpsa nuppu Jälgi kohe, et lugeda seda Feederis.

Kui sageli ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days postitab?

ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days postitab harvem kui kord nädalas. Viimane postitus avaldati 12 päeva tagasi.

Kas ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days RSS-voog töötab?

Jah. Feeder kontrollis seda umbes 1 tund tagasi ja voog vastas tavapäraselt.

Kuidas jälgida voogu ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days Feederis?

Klõpsa nuppu Jälgi kohe ja registreeru, kui sul pole veel kontot. Feederi tasuta pakett hõlmab kuni 200 voogu veebis, iPhone'is ja Androidis. Krediitkaarti pole vaja.

Jälgi voogu ClinicalTrials.gov: mezagitamab (TAK 079) | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days rakenduses Feeder

Feederi tasuta pakett hõlmab kuni 200 voogu veebis, iPhone'is ja Androidis. Krediitkaarti pole vaja.

Registreeru tasuta

Või logige sisse